The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells - PubMed (original) (raw)
. 2004 Sep 24;279(39):40593-600.
doi: 10.1074/jbc.M406639200. Epub 2004 Jul 23.
Affiliations
- PMID: 15277520
- DOI: 10.1074/jbc.M406639200
Free article
The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells
Amitha H Palamakumbura et al. J Biol Chem. 2004.
Free article
Abstract
Lysyl oxidase is an extracellular enzyme critical for the normal biosynthesis of collagens and elastin. In addition, lysyl oxidase reverts ras-mediated transformation, and lysyl oxidase expression is down-regulated in human cancers. Since suramin inhibits growth factor signaling pathways and induces lysyl oxidase in ras-transformed NIH3T3 cells (RS485 cells), we sought to investigate the effects of suramin on the phenotype of transformed cells and the role of lysyl oxidase in mediating these effects. Suramin treatment resulted in a more normal phenotype as judged by growth rate, cell cycle parameters, and morphology. beta-aminopropionitrile, the selective inhibitor of lysyl oxidase enzyme activity, was remarkably unable to block suramin-induced reversion. By contrast, ectopic antisense lysyl oxidase demonstrated that lysyl oxidase gene expression mediated phenotypic reversion. Since lysyl oxidase is synthesized as a 50 kDa precursor and processed to a 30 kDa active enzyme and 18 kDa propeptide, the effects of these two products on the transformed phenotype of RS485 cells were then directly assessed in the absence of suramin. Here we report, for the first time, that the lysyl oxidase propeptide, and not the lysyl oxidase enzyme, inhibits ras-dependent transformation as determined by effects on cell proliferation assays, growth in soft agar, and Akt-dependent induction of NF-kappaB activity. Thus, the lysyl oxidase propeptide, which is released during extracellular proteolytic processing of pro-lysyl oxidase, functions to inhibit ras-dependent cell transformation.
Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.
Similar articles
- Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts.
Palamakumbura AH, Sommer P, Trackman PC. Palamakumbura AH, et al. J Biol Chem. 2003 Aug 15;278(33):30781-7. doi: 10.1074/jbc.M305238200. Epub 2003 Jun 4. J Biol Chem. 2003. PMID: 12788924 - Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S, Pianetti S, Kagan HM, Sonenshein GE. Jeay S, et al. Mol Cell Biol. 2003 Apr;23(7):2251-63. doi: 10.1128/MCB.23.7.2251-2263.2003. Mol Cell Biol. 2003. PMID: 12640111 Free PMC article. - Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Wu M, Min C, Wang X, Yu Z, Kirsch KH, Trackman PC, Sonenshein GE. Wu M, et al. Cancer Res. 2007 Jul 1;67(13):6278-85. doi: 10.1158/0008-5472.CAN-07-0776. Cancer Res. 2007. PMID: 17616686 - Functions and Mechanisms of Pro-Lysyl Oxidase Processing in Cancers and Eye Pathologies with a Focus on Diabetic Retinopathy.
Trackman PC, Peymanfar Y, Roy S. Trackman PC, et al. Int J Mol Sci. 2022 May 3;23(9):5088. doi: 10.3390/ijms23095088. Int J Mol Sci. 2022. PMID: 35563478 Free PMC article. Review. - Copper, lysyl oxidase, and extracellular matrix protein cross-linking.
Rucker RB, Kosonen T, Clegg MS, Mitchell AE, Rucker BR, Uriu-Hare JY, Keen CL. Rucker RB, et al. Am J Clin Nutr. 1998 May;67(5 Suppl):996S-1002S. doi: 10.1093/ajcn/67.5.996S. Am J Clin Nutr. 1998. PMID: 9587142 Review.
Cited by
- Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis.
Min C, Zhao Y, Romagnoli M, Trackman PC, Sonenshein GE, Kirsch KH. Min C, et al. J Cell Biochem. 2010 Dec 1;111(5):1160-8. doi: 10.1002/jcb.22828. J Cell Biochem. 2010. PMID: 20717927 Free PMC article. - The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells.
Sato S, Trackman PC, Mäki JM, Myllyharju J, Kirsch KH, Sonenshein GE. Sato S, et al. Mol Cell Biol. 2011 Jul;31(13):2683-95. doi: 10.1128/MCB.01148-10. Epub 2011 May 2. Mol Cell Biol. 2011. PMID: 21536655 Free PMC article. - Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
Palamakumbura AH, Vora SR, Nugent MA, Kirsch KH, Sonenshein GE, Trackman PC. Palamakumbura AH, et al. Oncogene. 2009 Sep 24;28(38):3390-400. doi: 10.1038/onc.2009.203. Epub 2009 Jul 13. Oncogene. 2009. PMID: 19597471 Free PMC article. - Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J, Ping W, Zu Y, Sun W. Liu J, et al. Int J Clin Exp Pathol. 2014 Aug 15;7(9):6040-7. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25337249 Free PMC article. - Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide.
Ozdener GB, Bais MV, Trackman PC. Ozdener GB, et al. Mol Oncol. 2016 Jan;10(1):1-23. doi: 10.1016/j.molonc.2015.07.005. Epub 2015 Aug 6. Mol Oncol. 2016. PMID: 26297052 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases